Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The zinc finger protein 329 pseudogene (ENSG00000272383) is a **pseudogene** in the human genome corresponding to the zinc finger protein 329 gene. Zinc finger proteins are generally members of large families of DNA-binding proteins involved in transcriptional regulation and other genetic control mechanisms[1][3][7]. However, a *pseudogene* such as this does not encode a functional protein and is not known to play a direct biological, regulatory, or therapeutic role in cells. It should not be considered a drug target, biomarker, or relevant pharmacological receptor. There is no evidence for disease association, drug interactions, or safety issues related to this pseudogene. The correct, functional human gene is ZNF329, and not the pseudogene entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 329 pseudogene.